Showing results (1971-1980 of 2,495) with videos related to

Sort By:
Pageof 250
Health Expectations : an International Journal of Public Participation in Health Care and Health Policy|November 7, 2024
Development of the First Patient-Reported Experience Measure (PREM) for Hearing Loss in Audiology Care-My Hearing PREMSian K Smith, Georgina Burns O'Connell, Rebecca Knibb, et al.
Canadian Journal of Anaesthesia = Journal Canadien D'Anesthesie|July 11, 2023
Outcomes of critically ill older adults with COVID-19: a multicentre retrospective cohort studyKiyan Heybati, Eric K C Wong, Jennifer Watt, et al.
Family Relations|July 15, 2026
A coparent intervention to prevent prenatal stress and depression symptoms in families with lower incomesRachel J Herman, Alexandrea L Craft, Christina A Rowley, et al.
BMJ Open|April 6, 2019
Underlying mechanisms of complex interventions addressing the care of older adults with multimorbidity: a realist reviewMonika Kastner, Leigh Hayden, Geoff Wong, et al.
Global Implementation Research and Applications|April 11, 2022
A Research Protocol for Implementation and Evaluation of a Patient-Focused eHealth Intervention for Chronic Kidney DiseaseMaoliosa Donald, Heather Beanlands, Sharon Straus, et al.
American Journal of Physiology. Regulatory, Integrative and Comparative Physiology|February 18, 2011
Effects of maturation and acidosis on the chaos-like complexity of the neural respiratory output in the isolated brainstem of the tadpole, Rana esculentaChristian Straus, Ziyad Samara, Marie-Noëlle Fiamma, et al.
Implementation Science : IS|February 10, 2017
Enhancing the reporting of implementation researchPaul M Wilson, Anne Sales, Michel Wensing, et al.
The Journal of Physical Chemistry. B|December 12, 2024
Interaction between the Polyelectrolytes Unfractionated Heparin and Universal Heparin Reversal AgentsHemant K Saini, A Louise Creagh, Chanel C La, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1990
A phase I toxicity, pharmacology, and dosimetry trial of monoclonal antibody OKB7 in patients with non-Hodgkin's lymphoma: effects of tumor burden and antigen expressionD A Scheinberg, D J Straus, S D Yeh, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 18, 2007
Maintaining the dose intensity of ICE chemotherapy with a thrombopoietic agent, PEG-rHuMGDF, may confer a survival advantage in relapsed and refractory aggressive non-Hodgkin lymphomaC H Moskowitz, P A Hamlin, J Gabrilove, et al.
Pageof 250